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Case Report
INTRODUCTION
Giant cell tumors (GCTs) are benign bone tumors arising from 
bone marrow, which account for about 5% of all biopsied pri-
mary bone tumors (1-3). GCTs arising in the head and neck re-
gion constitute approximately 2% of all GCTs, with the majori-
ty occurring in the sphenoid, ethmoid, or temporal bones (4, 5). 
To date, only a few reports of GCT arising from the craniofacial 
skeleton have been published, including from the parieto-occip-
ital bones (6, 7), maxilla (8, 9), zygomatic bone (10, 11), and la-
ryngeal cartilages (12). Only two studies have addressed treat-
ment of the mandible giant cell tumors, especially with skull base 
extension (13, 14). We present a case of GCT arising from the 
mandible.
CASE REPORT
A 53-year-old female was referred to our head and neck cancer 
clinic for a mass lesion at the mandibular area. The patient pre-
sented with left mandibular area pain, trismus, and facial numb-
ness that had persisted for 4 years. The patient had a medical 
history of osteoarthritis and osteoporosis. Physical examination 
revealed a 3×5 cm, hard, non-tender, and round mass on the 
left mandibular area. No other otorhinolaryngological and sys-
temic abnormalities were evident. 
  Computed tomography (CT) revealed an expansile tumor in-
volving the left mandibular ramus and temporomandibular joint 
area with bone destruction, extending to the base of middle cra-
nial fossa (Fig. 1). The tumor also extended to the left zygomatic 
bone. Magnetic resonance imaging (MRI) showed a 3×5 cm, 
heterogenous, well-defined, and expansile mass displacing the 
lateral pterygoid and temporalis muscle laterally, and involving 
the dura at the base of the middle cranial fossa (Fig. 2). On posi-
tron emission tomography-CT, elevated uptake of fludeoxyglu-
cose was noted at the left masticator space, and no metastatic 
lesion was observed. We initially considered ameloblastoma, 
lymphoma, chondrosarcoma, and giant cell tumor. The patient 
did not undergo preoperative biopsy because an imaging study 
and preoperative biopsy including fine needle aspiration is often 
not sufficient for a diagnosis. Based on the clinical and radio-
graphic criteria, this case was classified as an aggressive form 
(15). Therefore, we planned wide complete excision and recon-
struction. 
  The patient underwent mass excision using a modified Blair 
and cervical incisions to preserve the parotid gland. The mass 
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was resected with a segment of the left mandible and zygomatic 
bone (Fig. 3). The mass at the base of middle cranial fossa was 
also removed. The defect was reconstructed with iliac bone for 
mandible and temporal bone, and with fascia for cranial bone 
and dura (Fig. 4). No perioperative complications occurred.
  Microscopic examination revealed evenly distributed multi-
nucleated giant cells with surrounding stroma made up of spin-
dle cells. The giant cells displayed nucleoli that were similar to 
the surrounding spindle cells, suggestive of an osteoclastic type, 
which was consistent with a GCT (Fig. 5). The tumor involve-
ment of the dura was confirmed and resection margins at the 
surrounding area were free.  
  During a 1-year serial clinical and radiological follow-up, there 
was no evidence of recurrence (Fig. 6). The facial contour and 
masticatory function was well-preserved, though lateralization 
of the mandible was observed on the opening of mouth due to 
Fig. 3. (A) The mass lesion is exposed from infraparotid space (i) and from  supraparotid space (ii). (B) After mass resection and segmental 
mandibulectomy, the defect is observed from infraparotid space (i) and from supraparotid space (ii).
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Fig. 4. (A) Reconstruction of cranial bone and dura 
with left temporalis bone and fascia. (B) Reconstruc-
tion of mandible with iliac bone. A
B
Fig. 1. CT findings showing the TMJ lesion (arrow) and extension to 
the base of middle cranial fossa (arrowhead).
A B
Fig. 2. Facial MRI findings revealing 5×3 cm sized heterogenous, 
well-defined and expansile mass is located at the condylar fossa 
(arrow).
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pterygoid muscle injury.
DISCUSSION
GCT is a true neoplastic process originating from the undiffer-
entiated mesenchymal cells of the bone marrow (10). It is gener-
ally considered as benign (6) but severe bony destruction may 
result occasionally depending on the location and clinical pre-
sentation of the tumor, making tumor management very chal-
lenging (9). GCTs are usually mono-ostotic, although they may 
occasionally present in a polyostotic form, which is usually of a 
high grade (16).
  Patients with head and neck GCT may present with diverse 
symptoms depending on the location of primary lesion; symp-
toms include swelling, pain, epistaxis, neurological deficits, pro-
ptosis, visual defects, tinnitus, and hearing loss. In this case, GCT 
arising from the mandible caused temporo-mandibular pain and 
trismus. 
  Radiologic examination of GCT usually reveals a well-circum-
scribed lytic lesion surrounded by little or no sclerosis. The tu-
mors may infrequently break through the cortex and invade the 
soft tissue or the articular space (4, 17). A CT scan can provide 
a detailed assessment of GCT, showing the soft tissue mass of 
the lesion, cortical perforation, amount of bony destruction, and 
extension toward important adjacent anatomic structures such 
as the cranial base (9). MRI is superior to CT in delineating the 
extent of soft tissue tumor because of its improved contrast res-
olution (9). Bone scintigraphy shows increased radionuclide up-
take in the majority of GCTs (9).
  The differential diagnosis of GCT includes aneurismal bone 
cyst, chondroblastoma, dermoid cyst, chondrosarcoma, giant cell 
reparative granuloma, and pigmented villonodular synovitis (4, 
17). When an aggressive growth pattern is evident, the possibili-
ty of chondrosarcoma, osteosarcoma, and metastatic lesion can-
not be ruled out until confirmation by histologic examination. 
  The final diagnosis is established only on the basis of a biopsy 
(5). Histologically, GCTs are composed of multinucleated giant 
cells in a vascular stroma of epitheloid or spindle-shaped mono-
nuclear cells (18). The pathologic differential diagnosis of GCT is 
also extensive, including giant cell reparative granuloma, brown 
tumor of hyperparathyroidism, osteoblastoma, chondroblasto-
ma, aneurismal bone cyst, non-ossifying fibroma, foreign body 
reaction, and osteosarcoma with abundant giant cells. These can 
be difficult to distinguish from one another, particularly at fine 
needle aspiration or with frozen section specimens (9).
  Although it is regarded as benign, the giant cell tumor is local-
ly aggressive, and can even metastasize to the lung (17). Malig-
nant giant cell tumors have been reported (6), usually resulting 
from secondary malignant transformation after radiation treat-
ment (19). They present with marked atypia and pleomorphism 
with mitotic activity and vascular invasion (20).
  The treatment of choice of GCT is surgical excision (10). Re-
gardless of the site of presentation, partial resection or curretage 
results in a recurrence rate of up to 70%, whereas recurrence 
after wide resection is about 7% (21). Radiotherapy is generally 
avoided and is reserved for GCTs that are considered inopera-
ble, due to the risk of sarcomatous transformation (9), although 
some authors have advocated the use of radiotherapy in the 
management of GCT. Other treatment modalities including 
cryotherapy, chemotherapy, and curretage with adjuvant agents 
have been tried, but have yielded less effective results (10). GCTs 
generally recur within the first 3 years if recurrence occurs. But, 
Fig. 5. Evenly distributed multinucleated giant cell with surrounding 
stroma made up of spindle cells are shown, which were consistent 
with GCT.
Fig. 6. (A) Postoperative CT taken 1 year after the operation reveals 
no sign of recurrence. (B) The facial contour and masticatory func-
tion was well preserved, except for the lateralization of the mandible 
on the opening of mouth.
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continuous evaluation up to 5 years is recommended, since late 
distant metastasis have been reported (9).
  After extended GCT resection, reconstruction of the defect is 
often required for functional and esthetical reasons. Osteoartic-
ular autograft, allograft, and prosthetic reconstruction have been 
described (9, 22). A previous report suggested that the use of 
autologous tissue enables the rapid incorporation with a lower 
risk of infection, especially with vascularized grafts (9).
  In conclusion, GCT arising from the mandible is a rare disease 
whose diagnosis is difficult. Imaging and preoperative biopsy in-
cluding fine needle aspiration is often not sufficient to make the 
diagnosis. Therefore, the possibility of GCT should be included 
in the differential diagnosis of a bony lesion of craniofacial bones 
until a final diagnosis is made using a permanent pathologic 
specimen. Wide complete excision is required since incomplete 
excision results in a high incidence of recurrence.
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